ResoTher Pharma is a clinical stage biotechnology company based in Copenhagen, Denmark. Our mission is to develop innovative and effective treatments for patients with cardiovascular disease. We focus on addressing the role of inflammation in the disease process by utilizing peptide-based drugs that act as resolution therapy.

These drugs terminate the inflammatory response and promote tissue regeneration, offering new hope for patients in need. Our strategy revolves around acute, critical-care interventions for cardiovascular conditions with significant unmet medical needs. We believe that our unique pro-resolving therapies have the potential to provide additional therapeutic benefits to these patients.

At ResoTher Pharma, we are guided by a dedicated management team, supported by a board of directors, and advised by an esteemed scientific advisory board. By leveraging our expertise and collaborating with partners in the industry, we aim to deliver novel medicines that benefit those who require them most. To learn more about our groundbreaking work or to get in touch with us, please visit our website.

Together, we can make a difference in the lives of patients suffering from cardiovascular disease